The Download: AI’s trillion-dollar gamble and OpenAI’s biology data bid
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. What’s at stake in AI’s trillion-dollar gamble When Jessica Wachter, a finance professor at the University of Pennsylvania, wanted to assess AI’s impact on the economy over the next few years,….
Finance professor Jessica Wachter from the University of Pennsylvania analyzed the economic stakes of AI investments by focusing on a key fact: a small group of tech giants called hyperscalers are spending enormous sums to build AI data centers. By 2027, these expenditures are expected to reach nearly $1.1 trillion. Wachter’s research asks how quickly these companies’ earnings must grow to justify their spending by 2030. The findings suggest that AI companies will need an extraordinary boost in productivity just to break even. Hyperscalers refer to companies like Amazon, Microsoft, and Google that operate massive data centers to support cloud computing and AI services. The $1.1 trillion figure represents the projected total investment in AI infrastructure over the next few years, highlighting the scale of the financial gamble being taken on AI’s future economic impact.
OpenAI’s nonprofit arm, the OpenAI Foundation, is investing in a project to gather high-quality scientific datasets from the biotechnology industry. The initiative, proposed by policy analyst Ruxandra Teslo, aims to acquire detailed data from failed biotech companies during bankruptcy proceedings. This data could include regulatory filings, manufacturing strategies, and safety records, creating a valuable resource called “biotech’s lost archive.” The goal is to provide AI models with more information to drive breakthroughs in disease treatment and medical research. OpenAI’s involvement signals its interest in expanding AI’s role in biology, where large, high-quality datasets are critical for training advanced models. The project highlights the importance of data diversity in AI development, particularly in fields like medicine where precision and reliability are essential.
Warnings about the existential risks of AI, including the possibility of AI extinction, have gained traction in Silicon Valley. These concerns suggest that highly advanced AI systems could pose threats to human survival if not properly controlled. To explore these claims, MIT Technology Review hosted a Roundtable discussion featuring executive editor Niall Firth, senior AI editor Will Douglas Heaven, and AI reporter Grace Huckins. The conversation examined what AI extinction might entail, the seriousness of these risks, and potential measures to mitigate them. The term Roundtable refers to a moderated panel discussion where experts analyze complex topics. The discussion is now available on demand for subscribers, reflecting ongoing debates about AI’s long-term safety and governance amid rapid technological advancements.
Startup Generation Lab claims to have developed a drug that reverses aging in the bloodstream by blocking the systemic spread of aging and reawakening the body’s repair mechanisms. The approach is based on research by Irina Conboy, the company’s scientific founder, who found that connecting the circulatory systems of old and young mice improved healing in older animals. Generation Lab now says it has identified a combination of two existing drugs that can produce similar effects without physical intervention. However, the company has not disclosed the drugs’ identities, raising questions about transparency. The research targets rejuvenation, a process aimed at restoring youthful functions in aging tissues, and represents a potential breakthrough in anti-aging medicine.
Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg have publicly rejected proposals for a coordinated slowdown in AI development. Huang argued that new AI safety laws are unnecessary, while Zuckerberg claimed that market competition would naturally drive AI companies toward safer practices. These statements follow growing calls for stricter regulations on AI, including potential antitrust waivers that could exempt companies from competition laws. Antitrust waivers refer to exemptions from regulations designed to prevent monopolistic practices, which some argue could hinder innovation. The debate reflects broader divisions in the U.S. over how to balance AI advancement with safety and ethical concerns, as well as the role of government in regulating emerging technologies.
A Chinese hacking firm has reportedly used AI tools to analyze stolen government data and generate intelligence reports. These tools automate the process of sifting through large volumes of sensitive information, turning raw data into actionable insights. The development underscores the dual-use nature of AI, where technologies designed for beneficial purposes can also be exploited for malicious activities like cyber espionage. The incident highlights the challenges governments and organizations face in securing data against increasingly sophisticated cyber threats. It also raises questions about the ethical implications of AI in warfare and espionage, particularly as AI capabilities continue to advance.
Researchers have successfully used smart nanoparticles to deliver mRNA directly to tumors in mice, reprogramming the cells to attack cancerous growths. Smart nanoparticles are tiny particles designed to target specific cells or tissues, while mRNA (messenger RNA) is a molecule that instructs cells to produce proteins, including those that can trigger immune responses. This approach represents a novel strategy in cancer treatment, offering the potential for more precise and effective therapies. The study demonstrates the growing intersection of nanotechnology and biotechnology in medicine. However, the article notes that federal health agencies are reportedly abandoning mRNA-based treatments, indicating ongoing debates about the technology’s safety, efficacy, and regulatory challenges.
A digital simulation of a fruit fly’s brain, containing 166,000 neurons, has been taught to perform a variety of online tasks, including driving, trading Bitcoin, and playing the video game Doom. The project, known as a digital fly brain, serves as a model for studying neural networks and artificial intelligence. Researchers have used it to explore how complex behaviors can emerge from relatively simple neural architectures. The simulation highlights the potential of neuroscience-inspired AI, where biological principles are applied to develop more advanced and adaptable machine learning systems. While the digital fly brain is a simplified model, it provides insights into how AI might achieve human-like cognition in the future.
The U.S. Senate has blocked new cryptocurrency regulations amid a dispute over former President Donald Trump’s crypto holdings. The move was driven by demands for stricter ethics rules regarding Trump’s financial interests in the crypto industry. The rejection represents a setback for efforts to regulate the rapidly growing crypto market, which has faced criticism for its lack of transparency and susceptibility to fraud. The decision also reflects political divisions over the role of cryptocurrency in the U.S. economy. The crypto industry had hoped for clearer regulations to legitimize its operations, but the Senate’s action leaves the sector in a state of uncertainty, with ongoing debates about its future governance.
An entirely AI-generated sitcom has been released, but critics have panned it as poorly executed. One reviewer described the characters as *“dead-eyed waxworks,”* highlighting the limitations of current AI in creating engaging, human-like narratives. The show’s failure underscores the challenges AI faces in replicating the creativity, emotional depth, and spontaneity of human storytelling. While AI tools can generate scripts, dialogue, and even entire episodes, the results often lack coherence, originality, or emotional resonance. The incident serves as a reminder of the gap between AI’s technical capabilities and its ability to produce content that resonates with human audiences.
